Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04489524 · ClinicalTrials.gov registry record · NA

Smoking Cessation in NYC

A NA study of Smoking Cessation, sponsored by Temple University.

Completed
Registry status
NA
Development phase
139
Enrollment target
1
Study location

NCT04489524: Completed NA study of Smoking Cessation, sponsored by Temple University.

NCT04489524 is a NA study of Smoking Cessation that has completed, run by Temple University. The registered enrollment target is 139 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04489524, a NA study of Smoking Cessation, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target
1
Study location

Study Summary

The investigators tested the feasibility of a culturally and linguistically sensitive smoking cessation program with combined counseling and pharmacological components for Chinese smokers in New York City; identified factors and techniques that enhance the administration and appropriateness of the intervention program; and examined the effectiveness of this program on quit attempts, quit rates, and overall smoking reduction.

Primary Outcome

participants were asked whether they had smoked or had a puff on a cigarette and the number of cigarettes smoked in the past 7 days at multiple assessment points.

Conditions Studied

Interventions

  • BEHAVIORAL individualized counselor-led MI sessions
  • BEHAVIORAL general health education session
  • BEHAVIORAL NRT

Study Locations (1)

Pennsylvania

  • Center for Asian Health, Lewis Katz School of Medicine, Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2006-11
Est. Completion 2008-04-30
Phase NA
Temple University

163 total trials

What the finished NCT04489524 record still lists

NCT04489524 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which individualized counselor-led MI sessions is the first listed.

NCT04489524 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04489524 about?

NCT04489524 is a clinical study titled "Smoking Cessation in NYC". The investigators tested the feasibility of a culturally and linguistically sensitive smoking cessation program with combined counseling and pharmacological components for Chinese smokers in New York City; identified factors and techniques that enhance the administration and appropriateness of the i...

What is the current status of trial NCT04489524?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2006-11. Estimated completion is 2008-04-30.

What conditions does trial NCT04489524 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT04489524?

The interventions under investigation include: individualized counselor-led MI sessions (BEHAVIORAL), general health education session (BEHAVIORAL), NRT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04489524?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04489524 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04489524's enrollment target sits among peer trials

139 105th of 188 higher than 84 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05645380 · 139 participants · Phase 2

    Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

  • NCT06239272 · 139 participants · Phase 1

    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • NCT06252220 · 139 participants · Phase 1

    First in Human Study in Subjects With Obesity, But Otherwise Healthy

  • NCT06537128 · 139 participants · NA

    Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT04489524, the US trial registry maintained by the National Library of Medicine. NCT04489524 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.